Bayer’s $7.5B Roundup settlement faces a key decision for plaintiffs, with Apr. 27 Supreme Court hearing looming.
With thousands of cases piling up in U.S. courts, the company’s relief plans still face hurdles.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results